Connect Biopharma Holdings Net Debt Growth & History (CNTB)
Connect Biopharma Holdings's net debt was −$37.7M for fiscal 2025.
View full Connect Biopharma Holdings company overviewConnect Biopharma Holdings annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$37.7M | $40.4M | — |
| 2024 | 2024-12-31 | −$78.1M | $26.7M | — |
| 2023 | 2023-12-31 | −$104.7M | −$26.2M | — |
| 2022 | 2022-12-31 | −$78.5M | $189.1M | — |
| 2021 | 2021-12-31 | −$267.6M | — | — |
Connect Biopharma Holdings quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$26.4M | $13.3M | — |
| Q1 2026 | 2026-03-31 | −$45.3M | $1.4M | — |
| Q4 2025 | 2025-12-31 | −$37.7M | $40.4M | — |
| Q3 2025 | 2025-09-30 | −$37.1M | — | — |
| Q2 2025 | 2025-06-30 | −$39.8M | $69.8M | — |
| Q1 2025 | 2025-03-31 | −$46.8M | — | — |
| Q4 2024 | 2024-12-31 | −$78.1M | $26.7M | — |
| Q2 2024 | 2024-06-30 | −$109.5M | −$28.5M | — |
| Q4 2023 | 2023-12-31 | −$104.7M | −$26.2M | — |
| Q2 2023 | 2023-06-30 | −$81.0M | $59.8M | — |
| Q4 2022 | 2022-12-31 | −$78.5M | — | — |
| Q2 2022 | 2022-06-30 | −$140.8M | — | — |
Connect Biopharma Holdings net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Connect Biopharma Holdings's net debt increased from −$267.6M to −$37.7M, a change of $229.9M. The latest reported quarter, Q2 2026, shows −$26.4M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Connect Biopharma Holdings source filings ↗